Intravitreal Pharmacotherapies for Diabetic Macular Edema-Reference-Cited by-同舟云学术

Intravitreal Pharmacotherapies for Diabetic Macular Edema

Published:2022-01 Issue:1 Volume:129 Page:88-99
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Ehlers Justis P.,Yeh Steven,Maguire Maureen G.,Smith Justine R.,Mruthyunjaya Prithvi,Jain Nieraj,Kim Leo A.,Weng Christina Y.,Flaxel Christina J.,Schoenberger Scott D.,Kim Stephen J.

Funder

American Academy of Ophthalmology

Publisher

Elsevier BV

Subject

Ophthalmology

Reference31 articles.

1. Diabetes 2030: Insights from yesterday, today, and future trends;Rowley;Popul Health Manag,2017

2. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Diabetes control and complications trial research group;Ophthalmology,1995

3. Intravitreal aflibercept for diabetic macular edema;Korobelnik;Ophthalmology,2014

5. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stigmast-4-en-3-one from Euonymus alatus (Thunb.) Siebold. improves diabetic retinopathy and angiogenesis mediated by glucocorticoids receptor;Journal of Ethnopharmacology;2024-11

2. Résultats anatomiques et fonctionnels du protocole thérapeutique « 3 + PRN » dans le traitement de l’œdème maculaire diabétique;Journal Français d'Ophtalmologie;2024-09

3. Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease;Ophthalmology Science;2024-09

4. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography;Ophthalmology Science;2024-07

5. Exploitation of enhanced prime editing for blocking aberrant angiogenesis;Journal of Advanced Research;2024-07